Parrasia S, Rossa A, Varanita T, Checchetto V, De Lorenzi R, Zoratti M et al (2021) An Angiopep2-PAPTP construct overcomes the bloodbrain barrier
Some factors that influence the decision: Blood sugar concerns
A thoughtful approach leads to better long-term outcomes
When choosing among them, factors such as glycemic efficacy, weight effects and patient preferences may take precedence over concerns about major differences in [GI] risk. She added clinicians should continue to monitor for GI symptoms, particularly early in treatment, as these events, while uncommon, remain more frequent than with some other diabetes drug classes. According to Alkabbani and colleagues, recent trials revealed that dulaglutide (Trulicity, Eli Lilly), semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly) increased the risk for mild to serious GI adverse events like pancreatitis, constipation, nausea, vomiting and biliary disease
The chest area has numerous sebaceous glands that produce sebum, an oily substance meant to protect and moisturize the skin
Alcohol may increase side effects, especially during the first few weeks of treatment
